Area of research
Neurology · Cancer Research
Research interest
Research interests include Biology, microRNA, Myasthenia gravis, Gene, Competing endogenous RNA, and Computational biology.
Construction of ceRNA network mediated by circRNAs screening from microarray and identification of novel biomarkers for myasthenia gravis
Dimethyl fumarate modulates the immune environment and improves prognosis in the acute phase after ischemic stroke
Identification of potential immune-related hub genes in Parkinson’s disease based on machine learning and development and validation of a diagnostic classification model
LncPCD: a manually curated database of experimentally supported associations between lncRNA-mediated programmed cell death and diseases
Study of molecular patterns associated with ferroptosis in Parkinson’s disease and its immune signature
Identification of circulating immune landscape in ischemic stroke based on bioinformatics methods
RNA2Immune: A Database of Experimentally Supported Data Linking Non-Coding RNA Regulation to the Immune System
Integrated analysis of differentially expressed genes and a ceRNA network to identify hub lncRNAs and potential drugs for multiple sclerosis.
PubMed 2022cited by 7position: middle
Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma
LncRNA OIP5-AS1 modulates the proliferation and apoptosis of Jurkat cells by sponging miR-181c-5p to regulate IL-7 expression in myasthenia gravis
LncRNA LINC00680 Acts as a Competing Endogenous RNA and Is Associated With the Severity of Myasthennia Gravis
Human RNA Modifications Disease Database (HRMDD): A web resource for the molecular and clinical landscape of RNA modifications in human diseases
Construction of lncRNA-Mediated ceRNA Network for Investigating Immune Pathogenesis of Ischemic Stroke
Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses
Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis
Competitive endogenous RNA network and pathway-based analysis of LncRNA single-nucleotide polymorphism in myasthenia gravis
Identification of LINC00173 in Myasthenia Gravis by Integration Analysis of Aberrantly Methylated- Differentially Expressed Genes and ceRNA Networks
RNA2Immune: A Manually Curated Database of Experimentally Supported Data Linking Noncoding RNA Regulation to the Immune System
Overexpression of MicroRNA-9a-5p Ameliorates NLRP1 Inflammasome-mediated Ischemic Injury in Rats Following Ischemic Stroke
Xanthohumol protects neuron from cerebral ischemia injury in experimental stroke
Identification of the Regulatory Role of lncRNA SNHG16 in Myasthenia Gravis by Constructing a Competing Endogenous RNA Network
Inhibition of microglial receptor‐interacting protein kinase 1 ameliorates neuroinflammation following cerebral ischaemic stroke
Hospital and healthcare insurance system record–based epidemiological study of myasthenia gravis in southern and northern China
MicroRNAs and nervous system diseases: network insights and computational challenges
Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis
Network and Pathway-Based Analysis of Single-Nucleotide Polymorphism of miRNA in Temporal Lobe Epilepsy
Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility
Construction of a long non‑coding RNA‑mediated transcription factor and gene regulatory triplet network reveals global patterns and biomarkers for ischemic stroke
Global pathway view analysis of microRNA clusters in myasthenia gravis
Integrating multiple‐level molecular data to infer the distinctions between glioblastoma and lower‐grade glioma